[ad_1]
The countries of the world are rushing to produce vaccines against the Corona virus, through the factories of pharmaceutical companies spread over all the continents of the world to ensure rapid distribution and the safety of transport, but it seems that there is a large concentration of production processes in a limited number of countries, as three countries will produce doses that will exceed the population of the planet.
According to data analytics firm Airfinity, the United States has the capacity to produce approximately 4.7 billion doses of the COVID-19 vaccine through the end of 2021. According to results released by Deutsche Welle, India also has a high capacity to produce the vaccine with more than 3 billion possible doses. .
India is home to the world’s largest vaccine maker, the Indian Serology Institute, which produces nearly 1.4 billion doses per year, according to 2015 figures.
In comparison, the same report published by “Access to Medicine” showed that Sanofi produced one billion doses of the vaccine in the same year, while GlaxoSmithKline reached nearly 700 million doses, while Pfizer kept its figures secret. According to Statista, and seen by Al-Arabiya.net.
Despite the high number of doses, the Indian Institute of Serology obtained much smaller quantities of its vaccines, as most of them were sold at low prices locally. In 2015, its revenues were only around $ 566 billion, while Sanofi and Pfizer generated between $ 35 billion and $ 50 billion, respectively.
According to Deutsche Welle, AstraZeneca plans to produce 1 billion doses of the vaccine developed with “Oxford University” – the cheap and easy to store variant – at the facilities of the serum institute in India. A second vaccine, manufactured locally, has also been approved for cofaxin.
China ranks third in terms of the number of vaccines that can be produced, with around 1.9 billion doses, while the UK is in fourth place with just under one billion doses.
The largest producing countries are Corona vaccines
Source link
